Sankala Group’s Nuvalent NUVL Stock Holding History

Sankala Group’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.65K	Hold	17	–	–	﹤0.01%	502
2025 Q4	$1.73K	Buy	+17	New	+$1.68K	﹤0.01%	505

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sankala Group's NUVL Position: Q1 2026 in Review

Sankala Group held its Nuvalent (NUVL) position steady in Q1 2026 at 17 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #502.

Sankala Group first reported a position in NUVL in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.73K in Q4 2025. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

Sankala Group held 17 shares of Nuvalent worth $1.65K as of Q1 2026.
Sankala Group left its Nuvalent share count unchanged in Q1 2026.
Nuvalent made up ﹤0.01% of Sankala Group's portfolio in Q1 2026, its #502 holding.
Sankala Group first reported a position in Nuvalent in Q4 2025 and has held it in 2 quarters since.
Sankala Group's Nuvalent position peaked at $1.73K in Q4 2025.
263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.